Evidence map›Paper›PMID 27413184›Full record

ArticleThe Journal of biological chemistry2016

AMP-activated Protein Kinase Up-regulates Mitogen-activated Protein (MAP) Kinase-interacting Serine/Threonine Kinase 1a-dependent Phosphorylation of Eukaryotic Translation Initiation Factor 4E.

Xiaoqing Zhu, Vivian Dahlmans, Ramon Thali, Christian Preisinger, Benoit Viollet, J Willem Voncken, Dietbert Neumann

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. eIF4F controls ERK MAPK signaling in melanomas withProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. AMP-Activated Protein Kinase (AMPK)-Dependent Regulation of Renal Transport.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 6 countries.

Xiaoqing ZhuFrom the Department of Molecular Genetics, CARIM School of Cardiovascular Diseases and.
Vivian DahlmansDepartment of Molecular Genetics, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
Ramon Thalithe Institute of Cell Biology, ETH Zurich, 8093 Zurich, Switzerland.
Christian Preisingerthe Proteomics Facility, Interdisciplinary Center for Clinical Research (IZKF), RWTH University Hospital Aachen, 52074 Aachen, Germany.
Benoit Violletthe INSERM U1016, Institut Cochin, Department of Endocrinology, Metabolism and Diabetes, 75014 Paris, France, the CNRS UMR 8104, 75014 Paris, France, and the Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.
J Willem VonckenDepartment of Molecular Genetics, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands.
Dietbert NeumannFrom the Department of Molecular Genetics, CARIM School of Cardiovascular Diseases and the Institute of Cell Biology, ETH Zurich, 8093 Zurich, Switzerland, d.neumann@maastrichtuniversity.nl.ORCID 0000-0002-4316-684X
ETH Zurich · CHUniversity Medical Center · USDélégation Paris 5 · FRLaboratory of Molecular Genetics · PLUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AMP-activated protein kinase (AMPK) is a molecular energy sensor that acts to sustain cellular energy balance. Although AMPK is implicated in the regulation of a multitude of ATP-dependent cellular processes, exactly how these processes are controlled by AMPK as well as the identity of AMPK targets and pathways continues to evolve. Here we identify MAP kinase-interacting serine/threonine protein kinase 1a (MNK1a) as a novel AMPK target. Specifically, we show AMPK-dependent Ser(353) phosphorylation of the human MNK1a isoform in cell-free and cellular systems. We show that AMPK and MNK1a physically interact and that in vivo MNK1a-Ser(353) phosphorylation requires T-loop phosphorylation, in good agreement with a recently proposed structural regulatory model of MNK1a. Our data suggest a physiological role for MNK1a-Ser(353) phosphorylation in regulation of the MNK1a kinase, which correlates with increased eIF4E phosphorylation in vitro and in vivo.

Indexed as

AMP-Activated Protein KinasesAnimalsCell Line, TumorEukaryotic Initiation Factor-4EHumansIntracellular Signaling Peptides and ProteinsModels, MolecularPhosphorylationProtein Serine-Threonine KinasesProtein Structure, SecondaryAMP-Activated Protein KinaseseIF4E protein, mouseEukaryotic Initiation Factor-4EIntracellular Signaling Peptides and ProteinsMKNK1 protein, humanMknk1 protein, mouseProtein Serine-Threonine KinasesAMP-activated kinase (AMPK)eukaryotic translation initiation factor 4E (eIF4E)MAP kinase-interacting serine/threonine protein kinase 1a (MNK1a)mitogen-activated protein kinase (MAPK)post-translational modification (PTM)protein phosphorylationtranslation

Identifiers

PMID27413184
PMCPMC5016107
OpenAlexW2474978975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.